Healthcare provider profile · identity verified

Matthew W. Told, DO

Family Practice · GRANGEVILLE, ID · NPI 1477718716

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	212	57
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	198	47
Metoprolol Succinate	Metoprolol Succinate	197	42
Omeprazole	Omeprazole	179	50
Lisinopril	Lisinopril	175	45
Amlodipine Besylate	Amlodipine Besylate	172	40
Levothyroxine Sodium	Levothyroxine Sodium	144	34
Metformin Hcl	Metformin Hcl	133	33
Potassium Chloride	Potassium Chloride	125	33
Furosemide	Furosemide	121	34
Gabapentin	Gabapentin	100	30
Eliquis	Apixaban	98	21
Tramadol Hcl	Tramadol Hcl	97	16
Hydrochlorothiazide	Hydrochlorothiazide	92	23
Simvastatin	Simvastatin	86	22
Losartan Potassium	Losartan Potassium	82	22
Tamsulosin Hcl	Tamsulosin Hcl	80	26
Pantoprazole Sodium	Pantoprazole Sodium	71	15
Zolpidem Tartrate	Zolpidem Tartrate	71	18
Albuterol Sulfate Hfa	Albuterol Sulfate	68	21
Sertraline Hcl	Sertraline Hcl	68	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	60	14
Citalopram Hbr	Citalopram Hydrobromide	57	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	57	11
Lorazepam	Lorazepam	54	19
Morphine Sulfate Er	Morphine Sulfate	50	suppressed
Oxycodone Hcl	Oxycodone Hcl	50	suppressed
Famotidine	Famotidine	48	12
Glipizide	Glipizide	48	suppressed
Alprazolam	Alprazolam	46	suppressed
Clopidogrel	Clopidogrel Bisulfate	46	suppressed
Fluconazole	Fluconazole	44	19
Fluticasone Propionate	Fluticasone Propionate	44	17
Oxybutynin Chloride	Oxybutynin Chloride	44	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	43	11
Prednisone	Prednisone	42	29
Cefdinir	Cefdinir	39	37
Methocarbamol	Methocarbamol	39	suppressed
Montelukast Sodium	Montelukast Sodium	39	suppressed
Allopurinol	Allopurinol	37	suppressed
Ozempic	Semaglutide	37	suppressed
Atenolol	Atenolol	34	11
Metoprolol Tartrate	Metoprolol Tartrate	34	12
Bumetanide	Bumetanide	33	suppressed
Donepezil Hcl	Donepezil Hcl	33	suppressed
Spironolactone	Spironolactone	33	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	32	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	31	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	31	14
Acetaminophen-Codeine	Acetaminophen With Codeine	30	suppressed
Carvedilol	Carvedilol	29	suppressed
Cephalexin	Cephalexin	29	29
Meloxicam	Meloxicam	29	suppressed
Metronidazole	Metronidazole	29	17
Pregabalin	Pregabalin	29	suppressed
Trazodone Hcl	Trazodone Hcl	29	11
Duloxetine Hcl	Duloxetine Hcl	27	suppressed
Levetiracetam	Levetiracetam	27	suppressed
Ondansetron Odt	Ondansetron	27	12
Colchicine	Colchicine	26	suppressed
Metformin Hcl Er	Metformin Hcl	26	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	25	suppressed
Naproxen	Naproxen	24	suppressed
Warfarin Sodium	Warfarin Sodium	23	suppressed
Alendronate Sodium	Alendronate Sodium	22	suppressed
Clonazepam	Clonazepam	22	suppressed
Diazepam	Diazepam	22	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	22	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	19
Ciprofloxacin Hcl	Ciprofloxacin Hcl	21	18
Ezetimibe	Ezetimibe	21	suppressed
Fentanyl	Fentanyl	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Lovastatin	Lovastatin	20	suppressed
Methylprednisolone	Methylprednisolone	20	13
Metoclopramide Hcl	Metoclopramide Hcl	20	suppressed
Nexium	Esomeprazole Magnesium	20	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	14
Glipizide Er	Glipizide	18	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Clobetasol Propionate	Clobetasol Propionate	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Ibuprofen	Ibuprofen	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Spiriva Handihaler	Tiotropium Bromide	16	suppressed
Finasteride	Finasteride	15	suppressed
Methadone Hcl	Methadone Hcl	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	15
Aripiprazole	Aripiprazole	14	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	13
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Armour Thyroid	Thyroid,pork	13	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	13	suppressed
Lithium Carbonate Er	Lithium Carbonate	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	13	suppressed
Synthroid	Levothyroxine Sodium	13	suppressed
Testosterone Cypionate	Testosterone Cypionate	13	suppressed
Bupropion Hcl	Bupropion Hcl	12	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	11	suppressed
Azithromycin	Azithromycin	11	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Methotrexate	Methotrexate Sodium	11	suppressed
Metolazone	Metolazone	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Rexulti	Brexpiprazole	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed
Verapamil Hcl	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error